PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Mar-2023 Darolutamide receives EU approval for additional indication in prostate cancer Orion Corporation
02-Mar-2023 ANTIBODY RESPONSE AGAINST SARS-CoV-2 IN CANCER PATIENTS WITH B-CELL ABNORMALITIES Karl Landsteiner University of Health Sciences
02-Mar-2023 PureTech to Present at the Barclays Global Healthcare Conference PureTech
02-Mar-2023 Vitamin B5 could help improve red blood cell production in people with Myelodysplastic syndromes Queen Mary University of London and Francis Crick Institute
01-Mar-2023 Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1 Biophytis
01-Mar-2023 ImmunoGen Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of ImmunoGen's ADC Technology in the Development of Novel Targeted Conditioning Agents ImmunoGen
01-Mar-2023 Vivan Therapeutics Achieves Milestone for ECHS1 Therapeutics Discovery Vivan Therapeutics
01-Mar-2023 Cyntegrity and PwC Germany Join Forces to Offer Comprehensive Risk-Based Quality Management Solutions to the Pharmaceutical Industry Cyntegrity
01-Mar-2023 Ten new companies enter BioInnovation Institute’s Venture Lab program BioInnovation Institute (BII)
01-Mar-2023 Deprecated Yen attracting renewed international interest in Japanese pharma CPHI Japan 2023
01-Mar-2023 AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE & DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA® (Icosapent Ethyl) IN AUSTRALIA AND NEW ZEALAND AMARIN AND CSL SEQIRUS
01-Mar-2023 Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023 Mainz BioMed N.V.
28-Feb-2023 Santhera Secures Additional Funding Through a Private Placement of Shares and Upsizing of Existing Financing Arrangement Santhera Pharmaceuticals
28-Feb-2023 NuCana to Participate in Two Upcoming Investor Conferences NuCana plc
28-Feb-2023 iTeos to Present at Cowen 43rd Annual Health Care Conference iTeos Therapeutics, Inc.
28-Feb-2023 OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease OKYO Pharma
28-Feb-2023 ABPI response to the new Northern Ireland Brexit deal ABPI
28-Feb-2023 Rare and orphan disease expert Terebellum launches market access guide Terebellum
28-Feb-2023 MediClin AG: Disclosure of the preliminary figures of the 2022 financial year MediClin AG
28-Feb-2023 Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics Rhythm Pharmaceuticals